In this study we assessed the feasibility of quantitative parameters derived from amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in predicting the response to transcatheter arterial chemoembolization (TACE) treatment for hypervascular hepatocellular carcinoma (HCC). The combination model of quantitative parameters of APT and DKI showed good diagnostic performance in predicting the recurrence and postoperative liver decompensation. Therefore, APT and DKI can be used as potential imaging biomarkers to predict the effect of early-stage HCC after TACE treatment.
This abstract and the presentation materials are available to members only; a login is required.